The world is grappling with an increasing burden of kidney disease centers market, affecting over 85 million individuals globally. As kidney function declines, particularly when it falls below 15% of its normal capacity, the necessity for kidney replacement therapies, such as dialysis and transplantation, becomes critical. The US Renal Data System indicates a staggering wait of nearly four years for a kidney transplant in the United States, where 94,000 individuals are on the waiting list, the longest for any organ transplant. Remarkably, 15% of these have been waiting over five years. Know More: https://www.fairfieldmarketresearch.com/report/kidney-dialysis-centres-market
Disparity in Global Access to Kidney Replacement Therapy Accessibility to life-saving kidney replacement therapy varies significantly worldwide, particularly affecting low- and lower-middle-income countries. While high-income countries show better management with only 40% of patients lacking treatment, in low-income regions, this number soars to 96%. This disparity results in over 2 million deaths annually due to inadequate access to necessary care. Vast Differences in Treatment Availability Chronic dialysis, a lifeline for those with end-stage kidney disease (ESKD), presents a stark contrast in availability across different economic regions. From as high as 3251 pmp in Taiwan to a low of 0.5 pmp in Tanzania, the difference in dialysis prevalence is enormous. Similarly, the frequency of kidney transplants varies greatly, with Portugal having 693 pmp compared to only 3.1 pmp in the Bahamas. The Role of Dialysis Centers Dialysis centers are essential in managing kidney disease, offering both haemodialysis (HD) and peritoneal dialysis (PD). HD, though common, increases infection risks due to the